SlideShare a Scribd company logo
Dr M Ushashree
1st yr pg
Gandhi Medical College
 Introduction
 Phases of cough
 Cough reflex
 Types of cough
 Evaluation
 Investigations
 Treatment
 complications
 COUGH – it is a sudden and variable expiratory
thrust of air from the lungs through the air
passages associated with phonation, which
momentarily interrupts the physiological pattern
of breathing
 Without an effective cough reflex, there is a risk
of retaining airway secretions and aspirated
material predisposing to infection, atelectasis,
and respiratory compromise
 http://clinicalgate.com/wp-
content/uploads/2015/06/B9780323082037
000403_f040-001-9780323082037.jpg
Cough reflex initiated by chemical/mechanical
stimuli
This is carried by the afferents which are type c
and type 1 fibers and innervate pharynx, larynx
,large airways , terminal bronchiole and lung
parenchyma
Afferents travel via vagus and superior laryngeal
nerve
NTS in brain stem is the cough center
Efferents travel via vagus, phrenic, spinal motor
nerves to the larynx, trachea, bronchi,
diaphragm producing cough
MECHANO RECEPTORS NOCICEPTORS
CELL BODIES ARE IN NODOSE
GANGLION (ING VAGAL
GANGLION
CELL BODIES IN JUGULAR
GANGLION( SUP VAGAL
GANGLION)
SENSITIVE TO MECHANICAL
DISPLACEMENT
NOXIOUS CHEMICAL
IRRITANTS LIKE IRRITANT
VAPOURS ETC
LIMITED CHEMOSENSORY UNMYELINATED C FIBRES
ION CHANNELS BELONG TO
ASIC FAMILY acid-sensing
ion channel
ION CHANNELS BELONG TO
TRPV1transient receptor
potential vanilloid
AND TRPA1transient
receptor potential cation
channel, subfamily A,
TWO TYPES RAR AND SAR
 Voluntarily a person is capable of
suppressing the reflex cough for some time
 Cough can also be voluntarily induces (motor
and pre motor areas of brain)
 Neuro transmitters involved in voluntary
control of cough are seratonin, gaba,
dopamine, nmda(N-methyl-D-aspartate ) etc
 The central nervous pathways for cough show
interactions and plasticity
 ACUTE (<3 WKS)
 Tracheobronchitis
 Bronchopneumonia
 Viral pneumonia
 Acute-on-chronic bronchitis
 Pertussis
 Pulmonary embolism
 Foreign body aspiration
 Sudden onset – bronchial asthma ,asthmatic
bronchitis , whooping cough, foreign body
,LVF with PE
 SUB ACUTE (3-8 wks )
 trachiobronchitis ,
 pertussis ,
 post viral tussive syndrome
 CHRONIC > 8 wks
• Upper airway cough syndrome
• Asthma
• Gastro oesophageal reflux disorder
• Post viral cough
• Chronic bronchitis
• Bronchiectasis, cystic fibrosis
• Ace inhibitor induced Cough
• Environmental irritants.
• Infections – Mycoplasma Chlamydia
Bordetella
• Granulomatous disease – TB ,
Sarcoidosis.
• Neoplasms – Bronchogenic
carcinoma,Carcinoid tumor
• ILD
 Micro aspirations
 Zenker’s diverticulum
 CVS – Disorders of pericardium, CCF,
Vasculitis
 Tourette syndrome
 Habitual or psychogenic cough.
 Asymptomatic enlarged tonsils
 Based on expectoration
• Dry cough: pleural disorders , diseases of
interstitium, mediastinal lesions
• Productive cough: suppurative lung disease,
airway diseases
 Brassy/Gander cough –metallic sound d/t
compression of trachea by intra thoracic
space occupying lesions or aortic aneurysms
also known as leopards growl
 Bovine cough –loss of expulsive nature as in a
tumour pressing on the recurrent laryngeal
nerve
 Paroxysmal cough – whooping cough ,
chronic bronchitis, foreign body , bronchial
asthma
 Barking cough – involvement of epiglottis ,
croup( laryngo trachiobronchitis) , hysteria
 Whooping cough – pertussis
 Spluttering cough- s/I T-E fistula , cough
while swallowing
 Hacking – heavy smokers, chronic pharyngitis
or laryngitis
IMPAIRED COUGH
 Decreased expiratory-muscle strength
 Decreased inspiratory-muscle strength
 chest wall deformity
 Impaired glottic closure or tracheostomy
 Tracheomalacia
 Central respiratory depression (e.g.,
anesthesia, sedation)
 Efforts should be made to identify the cause
of cough
 A cough lasting than more than 3 wks
require a detailed evaluation
 Cough associated with or without sputum is
more important than the amount of sputum
and the presence or absence of sputum
should not be taken as a strict criterion for
diagnosis
 Considerations at 1st visit
 Determine the severity
 Assess the cause
 Plan investigation and treatment
 Cough: onset, duration, character,
triggers
 Sputum-volume & character
 Postural variations
 Diurnal variations
 Smoking, occupation
 Drug history(ACE inhibitors)
 Asthma: wheeze, nocturnal symptoms, atopy
 GE Reflux ass. Symptoms
 Rhinitis: PND, sinusitis, throat clearing, nasal
congestion
 chest pains, incontinence,
 syncope, anxiety, disturbed sleep
 Lobar pneumonia – the cough is initially dry
a/w chest pain later becomes productive
 Chronic bronchitis – productive cough for
most days of 3 months for 2 consecutive yrs
 Bronchiectasis – copious amt of foul smelling
sputum more on lying down
 Gastro esophageal reflux disorder -
Nonproductive cough often following meals
with or without symptoms of GERD
 Left ventricular failure - Cough intensifies
while supine, along with aggravation of
dyspnea
 Angiotensin-converting enzyme (ACE)
inhibitors Nonproductive cough, more
common in women, may occur at any time ,
neurokinin 1 receptor polymorphism
 Routine investigations
 Absolute eosinophil count
 Pulmonary function tests
 Sputum gram stain , culture sensitivity , zn
stain
 Chest x ray
 Ct chest
 Sinus x ray/CT sinus
 Quality of life questionnaires
 Leicester cough questionnaire used to assess
cough intensity and frequency
 Measurement of cough reflex- by inhalation
of tussive agent like capsaicin
 Visual analogue scales
 Cough lasting less than 3 wks
 Usually it is due to viral and bacterial
infections of upper respiratory tract
 Usually the cough resolves within 2 wks
 Other symptoms that can be associated
with cough are post nasal discharge ,
nasal obstruction, nasal discharge
 Rhinitis associated with common cold
may have mucopurulent discharge but it
is not an indication of antibiotics unless it
persists for more than 10 to 14 days
 Step 1: Identification and Treatment of
Obvious Causes
 Step 2: Focused Testing for and Treatment of
Asthma, Gastroesophageal Reflux, and
Rhinosinusitis
 Step 3: Investigations to Rule Out Rarer
Causes of Cough
 Step 4: Management of Idiopathic or
Refractory Chronic Cough
 Cough variant Asthma
 Upper airway cough syndrome
 Aspiration
 Habitual cough
 Foreign body
 Drugs Angiotensin converting enzyme inhibitors
 Chronic bronchitis
 Chronic idiopathic cough,
 narcotic cough suppressants, such as
codeine or hydrocodone
 Dexomethorphan can also be used
 Benzonatate
 Case series have reported benefit from off-
label use of gabapentin or amitryptyline for
chronic idiopathic cough.
 In paediatric age group cough more than 4
wks is considered chronic
 Most common cause of chronic cough in
infants is aspiration and congenital heart
defects
 2-5 yrs – foreign body inhalation , hyper
reactive airways
 Adolescents – hyper reactive airways,
infections
 ANTITUSSIVE AGENT
• Morphine
• Dihydro-
morphinone
• Codeine
• pholcode
ine
• Dexomet
horphan
• noscapin
e
,
• Diphenhydram
ine
• Benzonatate
• Triprolidine
 Depression of medullary centres or
associated higher centres.
 Increased threshold of cough centre
 An opium alkaloid.
 It is more selective for cough centre.
 Suppresses cough for about 6 hours.
 The antitussive action is blocked by
naloxone.
 Cough suppression occur with low doses of
opioids than those needed for
analgesia.(sub-analgesic dose 15 mg)
 Abuse liability is low, but present.
Adverse Effects
 •Constipation.
 •Respiratory depression & drowsiness
 Little/ no analgesic or addicting
property.
 Similar efficacy as antitussive to
codeine
 Is longer acting—–acts for 12 hours
or more.
 Given once or twice daily.
Adverse Effects
 Nausea
 Drowsiness
 •Depresses cough but has no
narcotic, analgesic or dependence
inducing properties.
 •Efficacy same as codeine, specially
useful in spasmodic cough.
Adverse Effects
 •Headache & nausea can occur
 raises threshold for cough & depresses
cough centre in medulla.
 It has been found to enhance the
analgesic action of morphine & other μ
receptors agonists
 As effective as codeine, does not depress
mucociliary function of the airway
mucosa.
 Devoid of addicting actions.
 Produces less constipation than codeine
 Antitussive action for 6 hours.
 it does not act through opioids
receptors.
Side effects:
 Dizziness, nausea, drowsiness & ataxia.
 It acts at the CNS level by inhibiting the
medullary cough centre
 In addition to this peripheral effects are
related to its antihistamine,
antiserotonergic and muscle-relaxant
properties
 it is used in the treatment of cough,
bronchospasm and related symptoms
 It has antihistamine with anticholinergic
properties
 Centrally acting with no addicting
properties
 the most common side effect is
drowsiness
 quick acting drug that can clear
congestion and stop runny noses in 15–
30 minutes
 Useful in cough in allergic conditions
 Diphenhydramine is an antihistamine
used to relieve symptoms of allergy,
hay fever, and the common cold.
 Commonly present in many cough
syrups
 Drowsiness, dizziness, constipation,
stomach upset, blurred vision
 Demulcents. promotes salivation & inhibit
impulses from inflamed mucosa
 Linctus Thick liquid preparation
containing sucrose and medicinal
substance
 Throat lozenges:They have lubricating
and soothing effect on irritated tissue of
throat may contain benzocaine or
dextromethorphan.
 selective NOP1 (nociceptin opioid 1) receptor
agonist
 TRPV1 antagonists
 TRPA1 antagonists
 Memantine, the non competitive NMDA
channel blocker
 The neurokinin-1 (NK1) receptor has been
implicated in the sensitization of synapses in
the nTS, and its antagonist (aprepitant) was
recently found to reduce cough in patients
with lung cancer
Drugs which render sputum less visous
Inhalational:
 •Acetylcysteine,
Oral :
 •Acetylcysteine,
 •Bromohexine,
 •Carbocysteine,
 •Methylcysteine.
Clinical Uses
 Acute & chronic bronchitis.
 Bronchial asthma
Drugs which ↑ bronchial secretions or
reduces its viscosity facilitating its removal
by coughing
 Ipecacuanha
 Ammonium chloride
 Ammonium bicarbonate.
 Terepin hydrate
 Potassium Iodide
 Guaiphenesin
 Sodium or Potassium citrate
RESPIRATORY
 Pneumothorax
 Subcutaneous emphysema
 Pneumomediastinum
 Pneumoperitoneum
 Laryngeal damage
CARDIOVASCULAR
 Cardiac dysrhythmias
 Loss of consciousness or cough syncope
 Subconjunctival hemorrhage
CENTRAL NERVOUS SYSTEM
 Syncope Headaches
 Cerebral air embolism
MUSCULOSKELETAL
 Intercostal muscle pain
 Rupture of rectus abdominis muscle
 Increase in serum creatine phosphokinase
 Cervical disc prolapse
CENTRAL NERVOUS SYSTEM
 Syncope Headaches
 Cerebral air embolism
MUSCULOSKELETAL
 Intercostal muscle pain
 Rupture of rectus abdominis muscle
 Increase in serum creatine phosphokinase
 Cervical disc prolapse
GASTROINTESTINAL
 Esophageal perforation
OTHER
 Social embarrassment
 Depression Urinary incontinence
 Disruption of surgical wounds
 Petechiae Purpura
cough-161117122251 (1).pdf

More Related Content

What's hot

Dry cough
Dry coughDry cough
Dry cough
rajeetam123
 
Hypoventilation and hyperventilation
Hypoventilation and hyperventilationHypoventilation and hyperventilation
Hypoventilation and hyperventilation
Beshr Nammouz
 
Mechanism of cough
Mechanism of coughMechanism of cough
Mechanism of cough
Abino David
 
Pulmonary auscultation
Pulmonary auscultationPulmonary auscultation
Pulmonary auscultation
VASS Yukon
 
aproch to patient with dyspnea
aproch to patient with dyspneaaproch to patient with dyspnea
aproch to patient with dyspnea
samaramajid
 
Pulmonary function test and bronchial challenge test
Pulmonary function test and bronchial challenge testPulmonary function test and bronchial challenge test
Pulmonary function test and bronchial challenge test
Chulalongkorn Allergy and Clinical Immunology Research Group
 
Cough investigations
Cough investigationsCough investigations
Cough investigationsAbino David
 
Respiratory Diseases II
Respiratory Diseases IIRespiratory Diseases II
Respiratory Diseases IIdiamondeye
 
Bronchiectasis final
Bronchiectasis final Bronchiectasis final
Bronchiectasis final
Dr.Manish Kumar
 
Bronchial Asthma
Bronchial AsthmaBronchial Asthma
Bronchial Asthma
Eneutron
 
Chronic Bronchitis
Chronic Bronchitis Chronic Bronchitis
Chronic Bronchitis Shahd Al Ali
 
ASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATIONASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATION
DJ CrissCross
 
Copd
CopdCopd
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
Virendra Hindustani
 
Bronchiectasis
Bronchiectasis   Bronchiectasis
Bronchiectasis
Rivindu Wickramanayake
 
Pathophysiology of copd
Pathophysiology of copdPathophysiology of copd
Pathophysiology of copd
Meshal AlEnzi
 
Approach to asthma
Approach to asthmaApproach to asthma
Approach to asthma
Dr Praman Kushwah
 

What's hot (20)

Dry cough
Dry coughDry cough
Dry cough
 
Hypoventilation and hyperventilation
Hypoventilation and hyperventilationHypoventilation and hyperventilation
Hypoventilation and hyperventilation
 
Mechanism of cough
Mechanism of coughMechanism of cough
Mechanism of cough
 
Pulmonary auscultation
Pulmonary auscultationPulmonary auscultation
Pulmonary auscultation
 
aproch to patient with dyspnea
aproch to patient with dyspneaaproch to patient with dyspnea
aproch to patient with dyspnea
 
Pulmonary function test and bronchial challenge test
Pulmonary function test and bronchial challenge testPulmonary function test and bronchial challenge test
Pulmonary function test and bronchial challenge test
 
Cough investigations
Cough investigationsCough investigations
Cough investigations
 
Respiratory Diseases II
Respiratory Diseases IIRespiratory Diseases II
Respiratory Diseases II
 
Bronchiectasis final
Bronchiectasis final Bronchiectasis final
Bronchiectasis final
 
Asthma versus COPD
Asthma versus COPDAsthma versus COPD
Asthma versus COPD
 
Bronchial Asthma
Bronchial AsthmaBronchial Asthma
Bronchial Asthma
 
Chronic Bronchitis
Chronic Bronchitis Chronic Bronchitis
Chronic Bronchitis
 
ASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATIONASTHMA GINA CLASSIFICATION
ASTHMA GINA CLASSIFICATION
 
Copd
CopdCopd
Copd
 
Cough suppressants & expectorants
Cough suppressants & expectorantsCough suppressants & expectorants
Cough suppressants & expectorants
 
Bronchiectasis
BronchiectasisBronchiectasis
Bronchiectasis
 
Bronchiectasis
Bronchiectasis   Bronchiectasis
Bronchiectasis
 
Cough
CoughCough
Cough
 
Pathophysiology of copd
Pathophysiology of copdPathophysiology of copd
Pathophysiology of copd
 
Approach to asthma
Approach to asthmaApproach to asthma
Approach to asthma
 

Similar to cough-161117122251 (1).pdf

cough and dyspnea
cough and dyspneacough and dyspnea
cough and dyspnea
Amit Goyal
 
cough approach by aMit!!! GMCH
cough approach by aMit!!! GMCHcough approach by aMit!!! GMCH
cough approach by aMit!!! GMCH
aMit!!!
 
Bokkisham Durgadevi ppt8.. gm20116 cough and breathing problem
Bokkisham Durgadevi ppt8.. gm20116 cough and breathing problemBokkisham Durgadevi ppt8.. gm20116 cough and breathing problem
Bokkisham Durgadevi ppt8.. gm20116 cough and breathing problem
sainiboyRicky
 
Respiratory System (2)
Respiratory System (2)Respiratory System (2)
Respiratory System (2)guest2379201
 
Bronchitis
BronchitisBronchitis
Bronchitis
Hari Nagar
 
bronchitis-200424105258.pdf
bronchitis-200424105258.pdfbronchitis-200424105258.pdf
bronchitis-200424105258.pdf
SaiyedShohzab
 
Obstructive lung disease
Obstructive lung disease Obstructive lung disease
Obstructive lung disease
Dr. Darayus P. Gazder
 
Approach patient with cough
Approach patient with cough Approach patient with cough
Approach patient with cough
SoM
 
BRONCHIAL ASTHMA.pptx
BRONCHIAL ASTHMA.pptxBRONCHIAL ASTHMA.pptx
BRONCHIAL ASTHMA.pptx
rajendra gopal
 
Bronchial asthma and it's management
Bronchial asthma and it's managementBronchial asthma and it's management
Bronchial asthma and it's management
RakhiYadav53
 
Asthma
AsthmaAsthma
Asthma
nirmal23485
 
Unit II. Respiratory system disorders.pptx
Unit II.  Respiratory system disorders.pptxUnit II.  Respiratory system disorders.pptx
Unit II. Respiratory system disorders.pptx
Sani191640
 
Bronchitis
BronchitisBronchitis
Bronchitis
Alappatt Viji
 
clinical features of tb.ppt
clinical features of tb.pptclinical features of tb.ppt
clinical features of tb.ppt
ShakibSheikh5
 
Evaluation of cough
Evaluation of coughEvaluation of cough
Evaluation of cough
DR.SHARIF AHSAN
 
5. Bronchial asthma treatment and prognosis .pdf
5. Bronchial asthma  treatment and prognosis  .pdf5. Bronchial asthma  treatment and prognosis  .pdf
5. Bronchial asthma treatment and prognosis .pdf
ShinilLenin
 
Approach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseasesApproach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseases
Tigreentertainment
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics danielrawand
 

Similar to cough-161117122251 (1).pdf (20)

cough and dyspnea
cough and dyspneacough and dyspnea
cough and dyspnea
 
cough approach by aMit!!! GMCH
cough approach by aMit!!! GMCHcough approach by aMit!!! GMCH
cough approach by aMit!!! GMCH
 
Bokkisham Durgadevi ppt8.. gm20116 cough and breathing problem
Bokkisham Durgadevi ppt8.. gm20116 cough and breathing problemBokkisham Durgadevi ppt8.. gm20116 cough and breathing problem
Bokkisham Durgadevi ppt8.. gm20116 cough and breathing problem
 
Respiratory System (2)
Respiratory System (2)Respiratory System (2)
Respiratory System (2)
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
bronchitis-200424105258.pdf
bronchitis-200424105258.pdfbronchitis-200424105258.pdf
bronchitis-200424105258.pdf
 
Obstructive lung disease
Obstructive lung disease Obstructive lung disease
Obstructive lung disease
 
Approach patient with cough
Approach patient with cough Approach patient with cough
Approach patient with cough
 
BRONCHIAL ASTHMA.pptx
BRONCHIAL ASTHMA.pptxBRONCHIAL ASTHMA.pptx
BRONCHIAL ASTHMA.pptx
 
Bronchial asthma and it's management
Bronchial asthma and it's managementBronchial asthma and it's management
Bronchial asthma and it's management
 
Asthma
AsthmaAsthma
Asthma
 
Unit II. Respiratory system disorders.pptx
Unit II.  Respiratory system disorders.pptxUnit II.  Respiratory system disorders.pptx
Unit II. Respiratory system disorders.pptx
 
Bronchitis
BronchitisBronchitis
Bronchitis
 
clinical features of tb.ppt
clinical features of tb.pptclinical features of tb.ppt
clinical features of tb.ppt
 
Evaluation of cough
Evaluation of coughEvaluation of cough
Evaluation of cough
 
5. Bronchial asthma treatment and prognosis .pdf
5. Bronchial asthma  treatment and prognosis  .pdf5. Bronchial asthma  treatment and prognosis  .pdf
5. Bronchial asthma treatment and prognosis .pdf
 
Approach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseasesApproach to patient with uper and lower airway diseases
Approach to patient with uper and lower airway diseases
 
Copd
CopdCopd
Copd
 
Wheezy chest in pediatrics
Wheezy chest in pediatrics Wheezy chest in pediatrics
Wheezy chest in pediatrics
 

More from Tabassum Saher

SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..
SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..
SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..
Tabassum Saher
 
PULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASES
PULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASESPULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASES
PULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASES
Tabassum Saher
 
cardiac assessment. basic assessment about the cardiac assessment
cardiac assessment. basic assessment about the cardiac assessmentcardiac assessment. basic assessment about the cardiac assessment
cardiac assessment. basic assessment about the cardiac assessment
Tabassum Saher
 
HUMIDIFICATION AND NEBULISATION PPT.pptx
HUMIDIFICATION AND NEBULISATION PPT.pptxHUMIDIFICATION AND NEBULISATION PPT.pptx
HUMIDIFICATION AND NEBULISATION PPT.pptx
Tabassum Saher
 
Biomech of swimming PRESENTATION OF BIOMECHANICS
Biomech of swimming PRESENTATION OF BIOMECHANICSBiomech of swimming PRESENTATION OF BIOMECHANICS
Biomech of swimming PRESENTATION OF BIOMECHANICS
Tabassum Saher
 
Dose-Response of drugs towards the human body
Dose-Response of drugs towards the human bodyDose-Response of drugs towards the human body
Dose-Response of drugs towards the human body
Tabassum Saher
 
PAHTN PPT FINAL (1).pptx
PAHTN PPT  FINAL (1).pptxPAHTN PPT  FINAL (1).pptx
PAHTN PPT FINAL (1).pptx
Tabassum Saher
 
BIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptx
BIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptxBIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptx
BIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptx
Tabassum Saher
 
DRUGS FOR SPUTUM CLEARANCE PPT.pptx
DRUGS FOR SPUTUM CLEARANCE PPT.pptxDRUGS FOR SPUTUM CLEARANCE PPT.pptx
DRUGS FOR SPUTUM CLEARANCE PPT.pptx
Tabassum Saher
 
Mk slides.ppt
Mk slides.pptMk slides.ppt
Mk slides.ppt
Tabassum Saher
 
4241841.ppt
4241841.ppt4241841.ppt
4241841.ppt
Tabassum Saher
 
EFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptx
EFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptxEFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptx
EFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptx
Tabassum Saher
 
drugdeliverysystems-160209092852.pdf
drugdeliverysystems-160209092852.pdfdrugdeliverysystems-160209092852.pdf
drugdeliverysystems-160209092852.pdf
Tabassum Saher
 
joints ppt 3rd sem.pptx
joints ppt 3rd sem.pptxjoints ppt 3rd sem.pptx
joints ppt 3rd sem.pptx
Tabassum Saher
 
ELBOW JOINT final.pptx
ELBOW JOINT final.pptxELBOW JOINT final.pptx
ELBOW JOINT final.pptx
Tabassum Saher
 
MUSCLE PPT 3RD SEM.pptx
MUSCLE PPT 3RD SEM.pptxMUSCLE PPT 3RD SEM.pptx
MUSCLE PPT 3RD SEM.pptx
Tabassum Saher
 
passive__movement_1.pptx
passive__movement_1.pptxpassive__movement_1.pptx
passive__movement_1.pptx
Tabassum Saher
 
Shoulder Complex PPT.ppt
Shoulder Complex PPT.pptShoulder Complex PPT.ppt
Shoulder Complex PPT.ppt
Tabassum Saher
 
ACTIVE MOVEMENTS.ppt
ACTIVE MOVEMENTS.pptACTIVE MOVEMENTS.ppt
ACTIVE MOVEMENTS.ppt
Tabassum Saher
 

More from Tabassum Saher (19)

SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..
SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..
SLEEP , TYPES OF SLEEP AND ITS MANAGEMENT PPT..
 
PULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASES
PULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASESPULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASES
PULMONARY HYPERTENSION, COMPLICATION OF LUNG DISEASES
 
cardiac assessment. basic assessment about the cardiac assessment
cardiac assessment. basic assessment about the cardiac assessmentcardiac assessment. basic assessment about the cardiac assessment
cardiac assessment. basic assessment about the cardiac assessment
 
HUMIDIFICATION AND NEBULISATION PPT.pptx
HUMIDIFICATION AND NEBULISATION PPT.pptxHUMIDIFICATION AND NEBULISATION PPT.pptx
HUMIDIFICATION AND NEBULISATION PPT.pptx
 
Biomech of swimming PRESENTATION OF BIOMECHANICS
Biomech of swimming PRESENTATION OF BIOMECHANICSBiomech of swimming PRESENTATION OF BIOMECHANICS
Biomech of swimming PRESENTATION OF BIOMECHANICS
 
Dose-Response of drugs towards the human body
Dose-Response of drugs towards the human bodyDose-Response of drugs towards the human body
Dose-Response of drugs towards the human body
 
PAHTN PPT FINAL (1).pptx
PAHTN PPT  FINAL (1).pptxPAHTN PPT  FINAL (1).pptx
PAHTN PPT FINAL (1).pptx
 
BIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptx
BIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptxBIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptx
BIOMECHANICS AND PATHOMECHANICS OF THORACIC SPINE.pptx
 
DRUGS FOR SPUTUM CLEARANCE PPT.pptx
DRUGS FOR SPUTUM CLEARANCE PPT.pptxDRUGS FOR SPUTUM CLEARANCE PPT.pptx
DRUGS FOR SPUTUM CLEARANCE PPT.pptx
 
Mk slides.ppt
Mk slides.pptMk slides.ppt
Mk slides.ppt
 
4241841.ppt
4241841.ppt4241841.ppt
4241841.ppt
 
EFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptx
EFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptxEFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptx
EFFECT OF PHYSCIAL STRENGTH TRAINING IN SEDENTARY POPULATION.pptx
 
drugdeliverysystems-160209092852.pdf
drugdeliverysystems-160209092852.pdfdrugdeliverysystems-160209092852.pdf
drugdeliverysystems-160209092852.pdf
 
joints ppt 3rd sem.pptx
joints ppt 3rd sem.pptxjoints ppt 3rd sem.pptx
joints ppt 3rd sem.pptx
 
ELBOW JOINT final.pptx
ELBOW JOINT final.pptxELBOW JOINT final.pptx
ELBOW JOINT final.pptx
 
MUSCLE PPT 3RD SEM.pptx
MUSCLE PPT 3RD SEM.pptxMUSCLE PPT 3RD SEM.pptx
MUSCLE PPT 3RD SEM.pptx
 
passive__movement_1.pptx
passive__movement_1.pptxpassive__movement_1.pptx
passive__movement_1.pptx
 
Shoulder Complex PPT.ppt
Shoulder Complex PPT.pptShoulder Complex PPT.ppt
Shoulder Complex PPT.ppt
 
ACTIVE MOVEMENTS.ppt
ACTIVE MOVEMENTS.pptACTIVE MOVEMENTS.ppt
ACTIVE MOVEMENTS.ppt
 

Recently uploaded

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
Vivekanand Anglo Vedic Academy
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
timhan337
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
MysoreMuleSoftMeetup
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
MIRIAMSALINAS13
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
CarlosHernanMontoyab2
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Thiyagu K
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
Peter Windle
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
Anna Sz.
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
Balvir Singh
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
EduSkills OECD
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
DhatriParmar
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 

Recently uploaded (20)

Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
The French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free downloadThe French Revolution Class 9 Study Material pdf free download
The French Revolution Class 9 Study Material pdf free download
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Honest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptxHonest Reviews of Tim Han LMA Course Program.pptx
Honest Reviews of Tim Han LMA Course Program.pptx
 
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
Mule 4.6 & Java 17 Upgrade | MuleSoft Mysore Meetup #46
 
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXXPhrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
Phrasal Verbs.XXXXXXXXXXXXXXXXXXXXXXXXXX
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf678020731-Sumas-y-Restas-Para-Colorear.pdf
678020731-Sumas-y-Restas-Para-Colorear.pdf
 
Unit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdfUnit 2- Research Aptitude (UGC NET Paper I).pdf
Unit 2- Research Aptitude (UGC NET Paper I).pdf
 
A Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in EducationA Strategic Approach: GenAI in Education
A Strategic Approach: GenAI in Education
 
Polish students' mobility in the Czech Republic
Polish students' mobility in the Czech RepublicPolish students' mobility in the Czech Republic
Polish students' mobility in the Czech Republic
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Operation Blue Star - Saka Neela Tara
Operation Blue Star   -  Saka Neela TaraOperation Blue Star   -  Saka Neela Tara
Operation Blue Star - Saka Neela Tara
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Francesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptxFrancesca Gottschalk - How can education support child empowerment.pptx
Francesca Gottschalk - How can education support child empowerment.pptx
 
The Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptxThe Accursed House by Émile Gaboriau.pptx
The Accursed House by Émile Gaboriau.pptx
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 

cough-161117122251 (1).pdf

  • 1. Dr M Ushashree 1st yr pg Gandhi Medical College
  • 2.  Introduction  Phases of cough  Cough reflex  Types of cough  Evaluation  Investigations  Treatment  complications
  • 3.  COUGH – it is a sudden and variable expiratory thrust of air from the lungs through the air passages associated with phonation, which momentarily interrupts the physiological pattern of breathing  Without an effective cough reflex, there is a risk of retaining airway secretions and aspirated material predisposing to infection, atelectasis, and respiratory compromise
  • 5.
  • 6. Cough reflex initiated by chemical/mechanical stimuli This is carried by the afferents which are type c and type 1 fibers and innervate pharynx, larynx ,large airways , terminal bronchiole and lung parenchyma Afferents travel via vagus and superior laryngeal nerve NTS in brain stem is the cough center Efferents travel via vagus, phrenic, spinal motor nerves to the larynx, trachea, bronchi, diaphragm producing cough
  • 7.
  • 8. MECHANO RECEPTORS NOCICEPTORS CELL BODIES ARE IN NODOSE GANGLION (ING VAGAL GANGLION CELL BODIES IN JUGULAR GANGLION( SUP VAGAL GANGLION) SENSITIVE TO MECHANICAL DISPLACEMENT NOXIOUS CHEMICAL IRRITANTS LIKE IRRITANT VAPOURS ETC LIMITED CHEMOSENSORY UNMYELINATED C FIBRES ION CHANNELS BELONG TO ASIC FAMILY acid-sensing ion channel ION CHANNELS BELONG TO TRPV1transient receptor potential vanilloid AND TRPA1transient receptor potential cation channel, subfamily A, TWO TYPES RAR AND SAR
  • 9.
  • 10.  Voluntarily a person is capable of suppressing the reflex cough for some time  Cough can also be voluntarily induces (motor and pre motor areas of brain)  Neuro transmitters involved in voluntary control of cough are seratonin, gaba, dopamine, nmda(N-methyl-D-aspartate ) etc  The central nervous pathways for cough show interactions and plasticity
  • 11.  ACUTE (<3 WKS)  Tracheobronchitis  Bronchopneumonia  Viral pneumonia  Acute-on-chronic bronchitis  Pertussis  Pulmonary embolism  Foreign body aspiration  Sudden onset – bronchial asthma ,asthmatic bronchitis , whooping cough, foreign body ,LVF with PE
  • 12.  SUB ACUTE (3-8 wks )  trachiobronchitis ,  pertussis ,  post viral tussive syndrome
  • 13.  CHRONIC > 8 wks • Upper airway cough syndrome • Asthma • Gastro oesophageal reflux disorder • Post viral cough • Chronic bronchitis • Bronchiectasis, cystic fibrosis • Ace inhibitor induced Cough • Environmental irritants.
  • 14. • Infections – Mycoplasma Chlamydia Bordetella • Granulomatous disease – TB , Sarcoidosis. • Neoplasms – Bronchogenic carcinoma,Carcinoid tumor • ILD
  • 15.  Micro aspirations  Zenker’s diverticulum  CVS – Disorders of pericardium, CCF, Vasculitis  Tourette syndrome  Habitual or psychogenic cough.  Asymptomatic enlarged tonsils
  • 16.  Based on expectoration • Dry cough: pleural disorders , diseases of interstitium, mediastinal lesions • Productive cough: suppurative lung disease, airway diseases
  • 17.  Brassy/Gander cough –metallic sound d/t compression of trachea by intra thoracic space occupying lesions or aortic aneurysms also known as leopards growl  Bovine cough –loss of expulsive nature as in a tumour pressing on the recurrent laryngeal nerve  Paroxysmal cough – whooping cough , chronic bronchitis, foreign body , bronchial asthma
  • 18.  Barking cough – involvement of epiglottis , croup( laryngo trachiobronchitis) , hysteria  Whooping cough – pertussis  Spluttering cough- s/I T-E fistula , cough while swallowing  Hacking – heavy smokers, chronic pharyngitis or laryngitis
  • 19.
  • 20.
  • 21.
  • 22. IMPAIRED COUGH  Decreased expiratory-muscle strength  Decreased inspiratory-muscle strength  chest wall deformity  Impaired glottic closure or tracheostomy  Tracheomalacia  Central respiratory depression (e.g., anesthesia, sedation)
  • 23.  Efforts should be made to identify the cause of cough  A cough lasting than more than 3 wks require a detailed evaluation  Cough associated with or without sputum is more important than the amount of sputum and the presence or absence of sputum should not be taken as a strict criterion for diagnosis
  • 24.  Considerations at 1st visit  Determine the severity  Assess the cause  Plan investigation and treatment
  • 25.  Cough: onset, duration, character, triggers  Sputum-volume & character  Postural variations  Diurnal variations  Smoking, occupation  Drug history(ACE inhibitors)
  • 26.  Asthma: wheeze, nocturnal symptoms, atopy  GE Reflux ass. Symptoms  Rhinitis: PND, sinusitis, throat clearing, nasal congestion  chest pains, incontinence,  syncope, anxiety, disturbed sleep
  • 27.  Lobar pneumonia – the cough is initially dry a/w chest pain later becomes productive  Chronic bronchitis – productive cough for most days of 3 months for 2 consecutive yrs  Bronchiectasis – copious amt of foul smelling sputum more on lying down  Gastro esophageal reflux disorder - Nonproductive cough often following meals with or without symptoms of GERD
  • 28.  Left ventricular failure - Cough intensifies while supine, along with aggravation of dyspnea  Angiotensin-converting enzyme (ACE) inhibitors Nonproductive cough, more common in women, may occur at any time , neurokinin 1 receptor polymorphism
  • 29.  Routine investigations  Absolute eosinophil count  Pulmonary function tests  Sputum gram stain , culture sensitivity , zn stain  Chest x ray  Ct chest  Sinus x ray/CT sinus
  • 30.  Quality of life questionnaires  Leicester cough questionnaire used to assess cough intensity and frequency  Measurement of cough reflex- by inhalation of tussive agent like capsaicin  Visual analogue scales
  • 31.  Cough lasting less than 3 wks  Usually it is due to viral and bacterial infections of upper respiratory tract  Usually the cough resolves within 2 wks  Other symptoms that can be associated with cough are post nasal discharge , nasal obstruction, nasal discharge
  • 32.  Rhinitis associated with common cold may have mucopurulent discharge but it is not an indication of antibiotics unless it persists for more than 10 to 14 days
  • 33.  Step 1: Identification and Treatment of Obvious Causes  Step 2: Focused Testing for and Treatment of Asthma, Gastroesophageal Reflux, and Rhinosinusitis  Step 3: Investigations to Rule Out Rarer Causes of Cough  Step 4: Management of Idiopathic or Refractory Chronic Cough
  • 34.
  • 35.
  • 36.  Cough variant Asthma  Upper airway cough syndrome  Aspiration  Habitual cough  Foreign body  Drugs Angiotensin converting enzyme inhibitors  Chronic bronchitis
  • 37.  Chronic idiopathic cough,  narcotic cough suppressants, such as codeine or hydrocodone  Dexomethorphan can also be used  Benzonatate  Case series have reported benefit from off- label use of gabapentin or amitryptyline for chronic idiopathic cough.
  • 38.  In paediatric age group cough more than 4 wks is considered chronic  Most common cause of chronic cough in infants is aspiration and congenital heart defects  2-5 yrs – foreign body inhalation , hyper reactive airways  Adolescents – hyper reactive airways, infections
  • 39.
  • 40.  ANTITUSSIVE AGENT • Morphine • Dihydro- morphinone • Codeine • pholcode ine • Dexomet horphan • noscapin e , • Diphenhydram ine • Benzonatate • Triprolidine
  • 41.  Depression of medullary centres or associated higher centres.  Increased threshold of cough centre
  • 42.  An opium alkaloid.  It is more selective for cough centre.  Suppresses cough for about 6 hours.  The antitussive action is blocked by naloxone.  Cough suppression occur with low doses of opioids than those needed for analgesia.(sub-analgesic dose 15 mg)  Abuse liability is low, but present. Adverse Effects  •Constipation.  •Respiratory depression & drowsiness
  • 43.  Little/ no analgesic or addicting property.  Similar efficacy as antitussive to codeine  Is longer acting—–acts for 12 hours or more.  Given once or twice daily. Adverse Effects  Nausea  Drowsiness
  • 44.  •Depresses cough but has no narcotic, analgesic or dependence inducing properties.  •Efficacy same as codeine, specially useful in spasmodic cough. Adverse Effects  •Headache & nausea can occur
  • 45.  raises threshold for cough & depresses cough centre in medulla.  It has been found to enhance the analgesic action of morphine & other μ receptors agonists  As effective as codeine, does not depress mucociliary function of the airway mucosa.
  • 46.  Devoid of addicting actions.  Produces less constipation than codeine  Antitussive action for 6 hours.  it does not act through opioids receptors. Side effects:  Dizziness, nausea, drowsiness & ataxia.
  • 47.  It acts at the CNS level by inhibiting the medullary cough centre  In addition to this peripheral effects are related to its antihistamine, antiserotonergic and muscle-relaxant properties  it is used in the treatment of cough, bronchospasm and related symptoms
  • 48.  It has antihistamine with anticholinergic properties  Centrally acting with no addicting properties  the most common side effect is drowsiness  quick acting drug that can clear congestion and stop runny noses in 15– 30 minutes  Useful in cough in allergic conditions
  • 49.  Diphenhydramine is an antihistamine used to relieve symptoms of allergy, hay fever, and the common cold.  Commonly present in many cough syrups  Drowsiness, dizziness, constipation, stomach upset, blurred vision
  • 50.  Demulcents. promotes salivation & inhibit impulses from inflamed mucosa  Linctus Thick liquid preparation containing sucrose and medicinal substance  Throat lozenges:They have lubricating and soothing effect on irritated tissue of throat may contain benzocaine or dextromethorphan.
  • 51.  selective NOP1 (nociceptin opioid 1) receptor agonist  TRPV1 antagonists  TRPA1 antagonists  Memantine, the non competitive NMDA channel blocker  The neurokinin-1 (NK1) receptor has been implicated in the sensitization of synapses in the nTS, and its antagonist (aprepitant) was recently found to reduce cough in patients with lung cancer
  • 52. Drugs which render sputum less visous Inhalational:  •Acetylcysteine, Oral :  •Acetylcysteine,  •Bromohexine,  •Carbocysteine,  •Methylcysteine. Clinical Uses  Acute & chronic bronchitis.  Bronchial asthma
  • 53. Drugs which ↑ bronchial secretions or reduces its viscosity facilitating its removal by coughing  Ipecacuanha  Ammonium chloride  Ammonium bicarbonate.  Terepin hydrate  Potassium Iodide  Guaiphenesin  Sodium or Potassium citrate
  • 54. RESPIRATORY  Pneumothorax  Subcutaneous emphysema  Pneumomediastinum  Pneumoperitoneum  Laryngeal damage CARDIOVASCULAR  Cardiac dysrhythmias  Loss of consciousness or cough syncope  Subconjunctival hemorrhage
  • 55. CENTRAL NERVOUS SYSTEM  Syncope Headaches  Cerebral air embolism MUSCULOSKELETAL  Intercostal muscle pain  Rupture of rectus abdominis muscle  Increase in serum creatine phosphokinase  Cervical disc prolapse
  • 56. CENTRAL NERVOUS SYSTEM  Syncope Headaches  Cerebral air embolism MUSCULOSKELETAL  Intercostal muscle pain  Rupture of rectus abdominis muscle  Increase in serum creatine phosphokinase  Cervical disc prolapse
  • 57. GASTROINTESTINAL  Esophageal perforation OTHER  Social embarrassment  Depression Urinary incontinence  Disruption of surgical wounds  Petechiae Purpura